Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis

Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis

Laura M. Alcântara, Thalita C.S. Ferreira, Fernanda R. Gadelha, Danilo C. Miguel

ARTIGO

Inglês

Agradecimentos: We would like to thank the reviewers for their insightful commentsand suggestions

Tritryps diseases are devastating parasitic neglected infections caused by Leishmania spp., Trypanosoma cruzi and Trypanosoma brucei subspecies. Together, these parasites affect more than 30 million people worldwide and cause high mortality and morbidity.

CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ

FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP

aberto

Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis

Laura M. Alcântara, Thalita C.S. Ferreira, Fernanda R. Gadelha, Danilo C. Miguel


										

Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis

Laura M. Alcântara, Thalita C.S. Ferreira, Fernanda R. Gadelha, Danilo C. Miguel

    Fontes

    International journal for parasitology: drugs and drug resistance

    Vol. 8, no. 3 (Dec., 2018), p. 430-439